Diarrhea • Rotaviral diarrhea • Gastroenteritis
Also available as Active Pharmaceutical Ingredient (API)
Autism and ADH prevention • Oral health • Caries prevention • Inhibition of Streptococcus mutans
- > Lactobacillus rhamnosus – GG (ATCC 53103)
Lactobacillus rhamnosus – GG (ATCC 53103)
Discover characteristics, functionalities and scientific support of Lactobacillus rhamnosus – GG (ATCC 53103).
Thearapeutical Area(s): Gastrointestinal tract, Gut brain Axis, Oral care
Age/Gender: Adults, Children
Scientific reference(s)
Anna Pärtty et al. A possible link between early probiotics intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric Research, Volume 77, Number 6, June 2015.
Wallis A. et al. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis / chronic fatigue syndrome: neuropsycholo- gical symptoms and sex comparisons. J Transl Med 2018, 16:24.
One of the most recognized probiotic strains in the world, with over 1000 publications and 300 clinical trials including several demonstrated significant benefits in oral health and caries prevention.
One of the most recognized probiotic strains in the world, with special regard to pediatric diarrhea, with over 1000 publications and 300 clinical studies from preterm infants to elderly population and pregnant women
